Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial
- Resource Type
- Article
- Authors
- Huber, Rudolf M.; Hansen, Karin H.; Paz-Ares Rodríguez, Luis; West, Howard L.; Reckamp, Karen L.; Leighl, Natasha B.; Tiseo, Marcello; Smit, Egbert F.; Kim, Dong-Wan; Gettinger, Scott N.; Hochmair, Maximilian J.; Kim, Sang-We; Langer, Corey J.; Ahn, Myung-Ju; Kim, Edward S.; Kerstein, David; Groen, Harry J.M.; Camidge, D. Ross
- Source
- In Journal of Thoracic Oncology March 2020 15(3):404-415
- Subject
- Language
- ISSN
- 1556-0864